The UK’s medicines regulator has authorised GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled chronic...
Lire la suiteBial has introduced a new sublingual formulation of apomorphine in the United Kingdom, providing an additional “rescue” treatment option...
Lire la suiteUS-based premium pet nutrition brand Nulo has officially entered the United Kingdom market, calling the move an important “milestone”...
Lire la suiteGenfit has announced encouraging preliminary findings from a phase 1b clinical trial evaluating its investigational therapy, GNS561, in combination...
Lire la suiteFinnish biotechnology company NADMED has announced the launch of the NADMED Award 2026, positioning it as a catalyst for...
Lire la suiteTitle21 Health Solutions, a portfolio company specialising in life science regulatory support, has joined the Blood and Cells Advocacy...
Lire la suite